Merck KGaA
DEEURMerck KGaA (XETRA:MRK) — Drug Manufacturers - Specialty & Generic. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 3. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
- Merck KGaA ADR — 1MRKX · MI US CIK 310158 · LEI 4YV9Y5M8S0BRK1RP0397 · ISIN US58933Y1055
Ettevõtte Kohta
- Veebileht
- merckgroup.com
- Sektor
- Healthcare · Drug Manufacturers - Specialty & Generic
- Peakontor
- Darmstadt, Germany
- Tegevjuht
- Belén Garijo
- Töötajad
- 60 348
- Asutatud
- 1668
- Börsil Alates
- 26.06.1998 (XETRA:MRK)
- Ringluses Olevad Aktsiad
- 129.24 mln
- Vabalt Kaubeldavad Aktsiad
- 128.87 mln
- Turukapitalisatsioon
- 59.93 mld EUR
- Siseringi Isikud
- 0%
- Institutsionaalsed Investorid
- 57.83%
Kirjeldus
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Dividendid
Merck KGaA (MRK) maksab dividende kord aastas. Aastas (12 kuud kuni viimase teatatud maksega): 2.2 EUR aktsia kohta (maksed: 1). See on umbes 1.59% praegusest aktsiahinnast. Makseajaloo põhjal oodatakse järgmist ex-dividendi kuupäeva umbes 26.04.2027.
| Ex-Kuupäev | Väljamakse | Summa | % | Tüüp | Tikker |
|---|---|---|---|---|---|
| 2026-04-27 | 2026-04-29 | 2.2000 EUR | 1.6/1.6 % | aastane | XETRA:MRK |
| 2025-04-28 | 2025-04-30 | 2.2000 EUR | 1.6/1.6 % | aastane | XETRA:MRK |
| 2024-04-29 | — | 2.2000 EUR | 1.6/1.6 % | aastane | XETRA:MRK |
| 2023-05-02 | — | 2.2000 EUR | 1.6/1.6 % | aastane | XETRA:MRK |
| 2022-04-25 | — | 1.8500 EUR | 1.3/1.3 % | aastane | XETRA:MRK |
Suurimad Omanikud
| Omanik | Osalus | Aktsiad | Aruande Kuupäev |
|---|---|---|---|
| First Eagle Funds-First… | 4.7% | 6.07 mln | 2026-07-31 |
| MFS Series Trust XVII-MF… | 1.78% | 2.3 mln | 2026-06-30 |
| First Eagle Funds-First… | 1.59% | 2.06 mln | 2026-07-31 |
| VANGUARD STAR FUNDS-Vang… | 1.48% | 1.91 mln | 2026-07-31 |
| Bridge Builder Trust-Bri… | 1.36% | 1.76 mln | 2026-06-30 |
| VANGUARD TAX-MANAGED FUN… | 0.98% | 1.27 mln | 2026-06-30 |
| MFS SERIES TRUST I-MFS R… | 0.76% | 988 028 | 2026-05-31 |
| iShares Trust-iShares Co… | 0.75% | 964 996 | 2026-08-31 |
| MFS SERIES TRUST X-MFS I… | 0.73% | 947 855 | 2026-05-31 |
| BNY Mellon Strategic Fun… | 0.41% | 532 200 | 2026-05-31 |
| Generali Investments Cee… | 0% | 6 236 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 4 926 | 2026-06-30 |
| Reik & Co., Llc | 0% | 4 000 | 2026-06-30 |
| Gamma Investing LLC | 0% | 34 | 2026-09-30 |
Logi Sisse Google